Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 (USOI) Price & Performance

Kymera Therapeutics Inc. Common StockTrade
Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037Trade

Price performance (Past 24H)

Key statistics

Kymera Therapeutics Inc. Common Stock vs Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 trades at $46.57 (market cap $318.07M). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 27.9× Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 for 49 Days on average.

KYMRUSOI
Market Cap
$8.88B$318.07M
Volume
1,028,790104,534
Sector
HealthIncome / Options Overlay
52-Week High
$127.31$61.17
52-Week Low
$55.80$42.27
Typical Hold Time
0 Days49 Days
Enterprise Value
$8.27B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037

USOI trades at $46.38 with a modest 0.29% daily gain, showing bullish technical momentum with strong moving average signals. The stock lacks traditional fundamental metrics as it's an ETN tracking credit-linked notes, not a conventional company. Recent technical indicators show mixed signals with neutral oscillators but strong trend strength. Support levels cluster around $45-46 with resistance at $46-47, indicating tight trading range dynamics.

As a structured product, USOI offers exposure to credit markets but carries unique risks including issuer credit risk and complex payout structures. The bullish technical setup suggests near-term upside potential, though investors must understand the instrument's specialized nature and sensitivity to credit market conditions rather than traditional equity fundamentals.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KYMR
100% Buy0% Sell
Avg holding period · 0 Days
USOI
100% Buy0% Sell
Avg holding period · 49 Days

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →

About Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037

USOI is an Exchange-Traded Note (ETN) issued by UBS that provides exposure to a covered call strategy on the United States Oil Fund (USO). It aims to generate high monthly income by capturing option premiums from the hypothetical sale of out-of-the-money call options on oil shares, offering a way to profit from crude oil's volatility even in a flat or range-bound market.

Read more on USOI →